JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB75830

Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y]

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal WASP/Wiskott-Aldrich syndrome protein antibody. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 8 publications.

View Alternative Names

IMD2, WAS, Actin nucleation-promoting factor WAS, Wiskott-Aldrich syndrome protein, WASp

3 Images
Flow Cytometry (Intracellular) - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (AB75830)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (AB75830)

Intracellular Flow Cytometry analysis of U-937 (Human histiocytic lymphoma monocyte) cells labeling WASP/Wiskott-Aldrich syndrome protein with Purified ab75830 at 1/30 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunocytochemistry/ Immunofluorescence - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (AB75830)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (AB75830)

Immunocytochemistry analysis of TF-1 (Human bone marrow erythroblast) cells labeling WASP/Wiskott-Aldrich syndrome protein with Purified ab75830 at 1/50 dilution (5.88 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488,ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Western blot - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (AB75830)
  • WB

Unknown

Western blot - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (AB75830)

Blocking buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] (ab75830) at 1/10000 dilution

Lane 1:

TF-1 (Human Erythroleukemia erythroblast) whole cell lysate at 15 µg

Lane 2:

U-937 (Human histiocytic lymphoma monocyte) whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 53 kDa

Observed band size: 60 kDa

false

  • Carrier free

    Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-WASP/Wiskott-Aldrich syndrome protein antibody [EP2541Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP2541Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/30", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Effector protein for Rho-type GTPases that regulates actin filament reorganization via its interaction with the Arp2/3 complex (PubMed : 12235133, PubMed : 12769847, PubMed : 16275905). Important for efficient actin polymerization (PubMed : 12235133, PubMed : 16275905, PubMed : 8625410). Possible regulator of lymphocyte and platelet function (PubMed : 9405671). Mediates actin filament reorganization and the formation of actin pedestals upon infection by pathogenic bacteria (PubMed : 18650809). In addition to its role in the cytoplasmic cytoskeleton, also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed : 20574068). Promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed : 29925947).
See full target information WAS

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

International journal of genomics 2024:2277956 PubMed38410787

2024

A Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family.

Applications

Unspecified application

Species

Unspecified reactive species

Lingyu Wang,Jie Zhang,Linna Lu,Juan Ren,Yaofang Zhang,Lidong Zhao,Wukang Shen,Xucheng Hu,Shuai Fang,Xiaomei Lu,Gang Wang,Linhua Yang

eLife 12: PubMed37162507

2023

ARPC5 isoforms and their regulation by calcium-calmodulin-N-WASP drive distinct Arp2/3-dependent actin remodeling events in CD4 T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Lopamudra Sadhu,Nikolaos Tsopoulidis,Md Hasanuzzaman,Vibor Laketa,Michael Way,Oliver T Fackler

Nature biotechnology 41:1434-1445 PubMed36732477

2023

Synapse-tuned CARs enhance immune cell anti-tumor activity.

Applications

Unspecified application

Species

Unspecified reactive species

Peter J Chockley,Jorge Ibanez-Vega,Giedre Krenciute,Lindsay J Talbot,Stephen Gottschalk

Nature medicine 28:71-80 PubMed35075289

2022

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

A Magnani,M Semeraro,F Adam,C Booth,L Dupré,E C Morris,A Gabrion,C Roudaut,D Borgel,A Toubert,E Clave,C Abdo,G Gorochov,R Petermann,M Guiot,M Miyara,D Moshous,E Magrin,A Denis,F Suarez,C Lagresle,A M Roche,J Everett,A Trinquand,M Guisset,J Xu Bayford,S Hacein-Bey-Abina,A Kauskot,R Elfeky,C Rivat,S Abbas,H B Gaspar,E Macintyre,C Picard,F D Bushman,A Galy,A Fischer,E Six,A J Thrasher,M Cavazzana

Scandinavian journal of immunology 95:e13115 PubMed34758123

2021

Clinical and molecular characteristics of Wiskott-Aldrich Syndrome in five unrelated Chinese families.

Applications

Unspecified application

Species

Unspecified reactive species

Jiali Jiang,Junli Zhou,Manlv Wei,Sanjeev Singh,Lauriane Nikuze,Lifang Huang,Yuping Li,Jinxia Jiang,Hongying Wei

Medicine 100:e25527 PubMed33879693

2021

Clinical and genetic analysis of 2 rare cases of Wiskott-Aldrich syndrome from Chinese minorities: Two case reports.

Applications

Unspecified application

Species

Unspecified reactive species

Haifeng Liu,Yanchun Wang,Yangfang Li,Lvyan Tao,Yu Zhang,Xiaoli He,Yuantao Zhou,Xiaoning Liu,Yan Wang,Li Li

Nature communications 11:4034 PubMed32788576

2020

Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Rajeev Rai,Marianna Romito,Elizabeth Rivers,Giandomenico Turchiano,Georges Blattner,Winston Vetharoy,Dariusz Ladon,Geoffroy Andrieux,Fang Zhang,Marta Zinicola,Diego Leon-Rico,Giorgia Santilli,Adrian J Thrasher,Alessia Cavazza

Journal of cell science 133: PubMed31964710

2020

Myo1e modulates the recruitment of activated B cells to inguinal lymph nodes.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel A Girón-Pérez,Eduardo Vadillo,Michael Schnoor,Leopoldo Santos-Argumedo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com